Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx’s first approved product for the treatment of irritable bowel syndrome with constipation (IBS-C) is available in the United States and Canada. Ardelyx is developing XPHOZAH® (tenapanor), a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis, which has completed three successful Phase 3 trials.
As a member of the Ardelyx Sales team, the Area Business Director (Nephrology) will cultivate and maintain a strong direct customer-facing presence with nephrology healthcare providers, their office/clinic staff, and their affiliated dialysis center personnel as/if needed. The ABD will help establish Ardelyx as a company that advances patient care with novel mechanism medicines that meet important clinical needs.
Area Business Director (Nephrology)
Responsibilities:
Subscribe to Rise newsletter